157 related articles for article (PubMed ID: 24121165)
1. Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?
Müller-Ladner U; Tyndall A; Czirjak L; Denton C; Matucci-Cerinic M;
Ann Rheum Dis; 2014 Feb; 73(2):324-7. PubMed ID: 24121165
[TBL] [Abstract][Full Text] [Related]
2. The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.
Tyndall A; Ladner UM; Matucci-Cerinic M
Curr Opin Rheumatol; 2008 Nov; 20(6):703-6. PubMed ID: 18946332
[TBL] [Abstract][Full Text] [Related]
3. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database.
Tyndall A; Mueller-Ladner U; Matucci-Cerinic M
Ann Rheum Dis; 2005 Jul; 64(7):1107. PubMed ID: 15958775
[No Abstract] [Full Text] [Related]
5. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database.
Ingegnoli F; Ardoino I; Boracchi P; Cutolo M;
Microvasc Res; 2013 Sep; 89():122-8. PubMed ID: 23792167
[TBL] [Abstract][Full Text] [Related]
6. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Walker KM; Pope J; ;
J Rheumatol; 2011 Jul; 38(7):1326-8. PubMed ID: 21459952
[TBL] [Abstract][Full Text] [Related]
7. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
Walker UA; Tyndall A; Czirják L; Denton CP; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Matucci-Cerinic M;
Ann Rheum Dis; 2009 Jun; 68(6):856-62. PubMed ID: 18625615
[TBL] [Abstract][Full Text] [Related]
8. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
10. EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.
Beyer C; Distler JH; Allanore Y; Aringer M; Avouac J; Czirják L; Cutolo M; Damjanov N; Del Galdo F; Fligelstone K; Guiducci S; Kowal-Bielecka O; van Laar JM; Martucci-Cerinic M; Müller-Ladner U; Riemekasten G; Tarner IH; Tyndall A; Kennedy AT; Valentini G; Vettori S; Walker UA; Denton C; Distler O;
Ann Rheum Dis; 2011 Jul; 70(7):1178-82. PubMed ID: 21285118
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.
Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; ; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz EJ; Richter J; Cozzi F; Rozman B; Mallia CM; Gabrielli A; Farge D; Kiener HP; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara LM; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar JM; Kaltwasser JP; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva JA; Jacobsen S; Worm M; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov EL; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver RM; Antivalle M; Espinosa IB; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu RM; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun JB; Alhasani S; Distler JH; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz MT; Cantatore FP; Strauss G; von Mülhen CA; Pozzi MR; Eyerich K; Szechinski J; Keiserman M; Houssiau FA; Román-Ivorra JA; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato GF; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara V; Olas J; Salsano F; Oksel F; Tanaseanu CM; Foti R; Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst DE
J Rheumatol; 2010 Jul; 37(7):1488-501. PubMed ID: 20551097
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
Pellar RE; Pope JE
Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
[TBL] [Abstract][Full Text] [Related]
13. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
[TBL] [Abstract][Full Text] [Related]
14. [Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].
Becker MO; Müller-Ladner U; Riemekasten G
Z Rheumatol; 2010 Jun; 69(4):310-7. PubMed ID: 20490516
[TBL] [Abstract][Full Text] [Related]
15. Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative.
Vidal C; Ruano C; Bernardino V; Lavado Carreira P; Lladó A; Santos MC; Gruner H; Panarra A; Riso N; Moraes-Fontes MF
Acta Med Port; 2018 Jun; 31(6):312-320. PubMed ID: 30020876
[TBL] [Abstract][Full Text] [Related]
16. Registries in systemic sclerosis: a worldwide experience.
Galluccio F; Walker UA; Nihtyanova S; Moinzadeh P; Hunzelmann N; Krieg T; Steen V; Baron M; Sampaio-Barros P; Kayser C; Nash P; Denton CP; Tyndall A; Müller-Ladner U; Matucci-Cerinic M
Rheumatology (Oxford); 2011 Jan; 50(1):60-8. PubMed ID: 21148153
[TBL] [Abstract][Full Text] [Related]
17. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells.
Distler JH; Allanore Y; Avouac J; Giacomelli R; Guiducci S; Moritz F; Akhmetshina A; Walker UA; Gabrielli A; Müller-Ladner U; Tyndall A; Matucci-Cerinic M; Distler O;
Ann Rheum Dis; 2009 Feb; 68(2):163-8. PubMed ID: 18653485
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database.
Foocharoen C; Distler O; Becker M; Müller-Ladner U; von Mühlen C; Leuchten N; Walker UA
Scand J Rheumatol; 2012 May; 41(3):243-6. PubMed ID: 22309107
[No Abstract] [Full Text] [Related]
19. Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.
Fasano S; Riccardi A; Messiniti V; Caramaschi P; Rosato E; Maurer B; Smith V; Siegert E; De Langhe E; Riccieri V; Airó P; Mihai C; Avouac J; Zanatta E; Walker UA; Iannone F; García De la Peña Lefebvre P; Distler JHW; Vacca A; Distler O; Kowal-Bielecka O; Allanore Y; Valentini G
Ann Rheum Dis; 2019 Dec; 78(12):1681-1685. PubMed ID: 31422354
[TBL] [Abstract][Full Text] [Related]
20. Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern".
Smith V; Vanhaecke A; Herrick AL; Distler O; Guerra MG; Denton CP; Deschepper E; Foeldvari I; Gutierrez M; Hachulla E; Ingegnoli F; Kubo S; Müller-Ladner U; Riccieri V; Sulli A; van Laar JM; Vonk MC; Walker UA; Cutolo M;
Autoimmun Rev; 2019 Nov; 18(11):102394. PubMed ID: 31520797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
